Blood Pressure Variability and Its Relationship with Cognitive Function in Elderly Patients with Essential Hypertension and Type 2 Diabetes


  • Man Xu Hubei Yingcheng Chinese Medicine Hospital, Hubei, Yingcheng, 432400 China.



Objective: To investigate blood pressure variability of Elder hypertensives with type 2 diabetes and its relationship with cognition. Methods: A total of 143 elderly hypertensives were enrolled and divided into diabetic group (59 cases) and non-diabetic group (84 cases). The difference of general clinical characteristics, biochemical parameters, carotid ultrasound, a neuropsychological Scales and 24-hour ambulatory blood pressure (24hABPM) parameters between the two groups of subjects were compared. Then, the two groups (diabetic group and non-diabetic group) were further divided into (Mild cognitive dysfunction) subgroup (MMSE>26) and normal cognition subgroup (MMSE26), respectively. On the basis of MMSE scores, the difference of the parameters of ABPM between the two subgroups was analyzed. Results: Compared with the control group, 24hSBP, 24hPP, dSBP, dPP, nSBP, nPP, 24hSSD, dSSD, nSSD, 24hSCV, dSCV and nSCV were significantly higher in the diabetic group (p<0.05). However, cognition was lower in the diabetic group. No significant difference was found in the circadian pattern of blood pressure between the two groups. 24hSSD, dSSD, nSSD, 24hSCV, dSCV, nSCV were significantly higher in the MCI subgroup than normal cognition subgroup in both diabetic and non-diabetic groups(p<0.05), and they were negatively associated with scores of MMSE, the correlation coefficient were -0.235, -0.246, -0.341, -0.158, -0.222, -0.238 (0.001P<0.05). Conclusion: The study showed that in the elderly with hypertension, the mean systolic blood pressure and blood pressure variability were both higher in the diabetic group, and the cognition was lower instead. Whether or not with diabetes, blood pressure variability was always higher in the MCI subgroup. Blood pressure variability increased in patients with diabetes, and was associated with cognitive decline.


Mild cognitive dysfunction, Blood pressure variability, Diabetes, Hypertension, 24-hour ambulatory blood pressure


[1] Guariguata L, Whiting D R, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035 for the IDF Diabetes Atlas[J]. Diabetes Research and Clinical Practice, 2013.

[2] Zhen Hong. Current Situation and Prospect of Epidemiological Research on Alzheimer's Disease in China in Recent Years[J]. Geriatrics and Health Care, 2006, 11(4): 195-198.

[3] Petersen R C, Smith G E, Waring S C, et al. Mild cognitive impairment: clinical characterization and outcome[J]. Archives of neurology, 1999, 56(3): 303-308.

[4] Petersen R C, Negash S. Mild cognitive impairment: an overview[J]. CNS Spectrums: The International Journal of Neuropsychiatric Medicine, 2008, 13(1).

[5] Bell R D, Zlokovic B V. Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease[J]. Acta neuropathologica, 2009, 118(1): 103-113.

[6] Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease[J]. Nature genetics, 2009, 41(10): 1088-1093.

[7] Kudo T, Imaizumi K, Tanimukai H, et al. Are cerebrovascular factors involved in Alzheimer’s disease? [J]. Neurobiology of aging, 2000, 21(2): 215-224.

[8] Zhu, Jie, et al. "Intracranial artery stenosis and progression from mild cognitive impairment to Alzheimer disease." Neurology (2014): 10-1212.

[9] Li J, Wang Y J, Zhang M, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease[J]. Neurology, 2011, 76(17): 1485-1491.

[10] Sabayan B, Wijsman L W, Foster-Dingley J C, et al. Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study[J]. BMJ Open, 2013, 347(f4600).

[11] Marioni R E, Deary I J, Strachan M W, et al. Blood rheology and cognition in the Edinburgh Type 2 Diabetes Study[J]. Age and ageing, 2010, 39(3): 354-359.

[12] Revision Committee of the Guidelines for the Prevention and Treatment of Hypertension in China. China Guidelines for the Prevention and Treatment of Hypertension 2010 Edition [J]. Chinese Journal of Cardiology, 2011,39(7):579-616.

[13] Chinese Medical Association, Diabetes Society of Chinese Medical Association. Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2010 Edition, Discussion Draft), 2010.11.10.

[14] Inukai T, Inukai Y, Matsutomo R, et al. Clinical usefulness of doxazosin in patients with type 2 diabetes complicated by hypertension: effects on glucose and lipid metabolism[J]. Journal of international medical research, 2004, 32(2): 206-213.

[15] Zeng G, Nystrom F H, Ravichandran L V, et al. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells[J]. Circulation, 2000, 101(13): 1539-1545.

[16] Kanemaru A, Kanemaru K, Kuwajima I. The effects of short-term blood pressure variability and nighttime blood pressure levels on cognitive function[J]. Hypertension research: official journal of the Japanese Society of Hypertension, 2001, 24(1): 19-24.

[17] Roberts R O, Geda Y E, Knopman D S, et al. Association of duration and severity of diabetes mellitus with mild cognitive impairment[J]. Archives of neurology, 2008, 65(8): 1066-1073.


How to Cite

Xu, M. (2019). Blood Pressure Variability and Its Relationship with Cognitive Function in Elderly Patients with Essential Hypertension and Type 2 Diabetes. Journal of Geriatric Medicine, 1(1), 1–7.


Article Type